博纳西亚 is a professional contract research service provider focused on pharmaceutical R&D and clinical research, offering end-to-end clinical study and registration filing solutions for chemical drugs and biologics. The company serves sponsors by managing clinical trials and regulatory submissions. Recently it completed a near-RMB100 million B round financing. Proceeds are intended to accelerate the company’s internationalization and digital-intelligence (数智化) initiatives. Management plans to use the funding to further expand into North American and Southeast Asian markets. The company positions itself to help bring Chinese-origin innovation to broader international disease‑solution efforts and to strengthen China’s pharmaceutical industry competitiveness.

Total raised

$14M

Funding rounds

1

Latest round

Series B

Latest activity

Dec 2023